Omnicell Inc
OMCLOmnicell Inc (OMCL) is a healthcare technology company that specializes in medication management solutions, including automation and robotics for hospitals, long-term care, and retail pharmacy settings. Its products and services aim to improve medication safety, operational efficiency, and clinical outcomes through automation systems, inventory management, and analytics. Founded in 1992 and headquartered in Mountain View, California, Omnicell is recognized for its innovation in healthcare automation.
Company News
Omnicell's EVP & Chief Legal/Admin Officer Corey Manley sold 6,106 shares worth $243,629 on December 3, 2025, reducing his direct holdings by 5.85%. The sale occurred as the stock approached 52-week highs following strong Q3 results and the announcement of the company's new Titan XT automated dispensing system, which prompted analyst upgrades.
Evoke Pharma partnered with EVERSANA and Omnicell to expand access to GIMOTI nasal spray for gastroparesis treatment, targeting large gastroenterology practices and specialty pharmacies through strategic pharmacy network agreements.
The global pharmacy automation market is projected to grow from USD 6.99 billion in 2025 to USD 16.65 billion by 2034, driven by technological advancements, chronic disease management, and the need to reduce medication errors.
Several mid-cap stocks, including Globalstar, V.F. Corp, and Madrigal Pharmaceuticals, were among the top gainers last week. The companies reported positive financial results and business updates, leading to the stock price increases.
The global adherence packaging market size is expected to grow from $1.10 billion in 2023 to $1.93 billion by 2032, driven by the increasing number of chronic diseases and the need for quality medication. However, high costs and strict regulations pose challenges to the market's growth.
